Takeda Pharmaceutical Company Limited (NYSE:TAK) Q4 2022 Earnings Call Transcript

Christopher O’Reilly: Thank you very much for joining FY 2022 earnings announcement of Takeda. I will serve as MC, Head of IR. My name is O’Reilly.

Keep Reading →